Universal Ibogaine Return on Equity

Universal Ibogaine (IBO.V) currently reports a ROE of -542.44%. That is below the Healthcare sector average of -100.59%. Use the charts on this page to explore Universal Ibogaine's ROE history and peer comparisons.

Universal Ibogaine's ROE of -542.44% is lower than the Healthcare sector average of -100.59%. That is roughly 439.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Universal Ibogaine's current -542.44% should be judged against Healthcare norms (sector average: -100.59%) and against IBO.V's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -542.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -100.59%. From there, open related valuation or income-statement pages for Universal Ibogaine, and consider following IBO.V for alerts when major investors trade the stock.

Universal Ibogaine is classified in the Healthcare sector. On ROE, it currently shows -542.44% versus a sector average near -100.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IBO.V with unrelated industries.